BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
60 results:

  • 1. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
    Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
    Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Dissecting the genetic heterogeneity of gastric cancer.
    Hess T; Maj C; Gehlen J; Borisov O; Haas SL; Gockel I; Vieth M; Piessen G; Alakus H; Vashist Y; Pereira C; Knapp M; Schüller V; Quaas A; Grabsch HI; Trautmann J; Malecka-Wojciesko E; Mokrowiecka A; Speller J; Mayr A; Schröder J; Hillmer AM; Heider D; Lordick F; Pérez-Aísa Á; Campo R; Espinel J; Geijo F; Thomson C; Bujanda L; Sopeña F; Lanas Á; Pellisé M; Pauligk C; Goetze TO; Zelck C; Reingruber J; Hassanin E; Elbe P; Alsabeah S; Lindblad M; Nilsson M; Kreuser N; Thieme R; Tavano F; Pastorino R; Arzani D; Persiani R; Jung JO; Nienhüser H; Ott K; Schumann RR; Kumpf O; Burock S; Arndt V; Jakubowska A; Ławniczak M; Moreno V; Martín V; Kogevinas M; Pollán M; Dąbrowska J; Salas A; Cussenot O; Boland-Auge A; Daian D; Deleuze JF; Salvi E; Teder-Laving M; Tomasello G; Ratti M; Senti C; De Re V; Steffan A; Hölscher AH; Messerle K; Bruns CJ; Sīviņš A; Bogdanova I; Skieceviciene J; Arstikyte J; Moehler M; Lang H; Grimminger PP; Kruschewski M; Vassos N; Schildberg C; Lingohr P; Ridwelski K; Lippert H; Fricker N; Krawitz P; Hoffmann P; Nöthen MM; Veits L; Izbicki JR; Mostowska A; Martinón-Torres F; Cusi D; Adolfsson R; Cancel-Tassin G; Höblinger A; Rodermann E; Ludwig M; Keller G; Metspalu A; Brenner H; Heller J; Neef M; Schepke M; Dumoulin FL; Hamann L; Cannizzaro R; Ghidini M; Plaßmann D; Geppert M; Malfertheiner P; Gehlen O; Skoczylas T; Majewski M; Lubiński J; Palmieri O; Boccia S; Latiano A; Aragones N; Schmidt T; Dinis-Ribeiro M; Medeiros R; Al-Batran SE; Leja M; Kupcinskas J; García-González MA; Venerito M; Schumacher J
    EBioMedicine; 2023 Jun; 92():104616. PubMed ID: 37209533
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.
    Navsaria LJ; Li Y; Tripathy S; Cox ML; Hinkston CL; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Jun; 159(6):643-647. PubMed ID: 37074701
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrating Preoperative Computed Tomography and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Squamous Cell Carcinoma by Feature-Wise Attentional Graph Neural Network.
    Ding M; Cui H; Li B; Zou B; Fan B; Ma L; Wang Z; Li W; Yu J; Wang L
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):676-689. PubMed ID: 36641040
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between
    Fan Z; Chen R; Li M; Gu J; Li X; Wei W
    Expert Rev Mol Diagn; 2022 Sep; 22(9):895-903. PubMed ID: 36254608
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quaterization Derivatization with Bis(Pyridine) Iodine Tetrafluoroboride: High-Sensitivity Mass Spectrometric Analysis of Unsaturated Fatty Acids in Human Thyroid Tissues.
    Cheng J; Li Y; Wang Y; Zhang J; Sun T; Zhang L; Guo Y
    Anal Chem; 2022 Aug; 94(32):11185-11191. PubMed ID: 35916214
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immune Infiltration Represents Potential Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma.
    Li M; Chen P; Zhao Y; Feng X; Gao S; Qi Y
    Biomed Res Int; 2022; 2022():9009269. PubMed ID: 35795310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recognition of Key Genes in Human Anaplastic Thyroid cancer via the Weighing Gene Coexpression Network.
    Gong Y; Xu F; Deng L; Peng L
    Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid cancer.
    Li N; Zhang J; Meng X; Yao W
    J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Defining and Targeting Esophagogastric cancer Genomic Subsets With Patient-Derived Xenografts.
    Moy RH; Walch HS; Mattar M; Chatila WK; Molena D; Strong VE; Tang LH; Maron SB; Coit DG; Jones DR; Hechtman JF; Solit DB; Schultz N; de Stanchina E; Janjigian YY
    JCO Precis Oncol; 2022 Feb; 6():e2100242. PubMed ID: 35138918
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypermethylation of the
    Lao TD; Thieu HH; Nguyen DH; Le TAH
    Int J Biol Markers; 2022 Mar; 37(1):31-39. PubMed ID: 34935528
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Deep Learning for nasopharyngeal Carcinoma Identification Using Both White Light and Narrow-Band Imaging Endoscopy.
    Xu J; Wang J; Bian X; Zhu JQ; Tie CW; Liu X; Zhou Z; Ni XG; Qian D
    Laryngoscope; 2022 May; 132(5):999-1007. PubMed ID: 34622964
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum circulating miRNA-342-3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study.
    Krupinova J; Mokrysheva N; Petrov V; Pigarova E; Eremkina A; Dobreva E; Ajnetdinova A; Melnichenko G; Tiulpakov A
    Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00284. PubMed ID: 34505413
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
    Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
    [No Abstract]    [Full Text] [Related]  

  • 15. Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction.
    Piryaei M; Mehrparvar B; Mohammadian A; Shahriari F; Javidi MA
    Eur J Pharmacol; 2021 Nov; 910():174454. PubMed ID: 34454929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis.
    Chidambaram S; Markar SR
    Dis Esophagus; 2022 Feb; 35(2):. PubMed ID: 34286823
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric cancer.
    Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
    JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
    Patil S
    Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddon Mallee region of Victoria: A retrospective cohort study.
    Conway P; Leach M; Tejani N; Robinson A; Shethia Y; Solo I
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):242-250. PubMed ID: 33634598
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
    Choi SY; Lee E; Kim E; Chung MK; Son YI; Baek CH; Jeong HS
    BMC Cancer; 2021 Feb; 21(1):178. PubMed ID: 33602169
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.